UPHEALTH INC (UPH) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:UPH • US91532B2007

0.3 USD
+0.03 (+9.13%)
Last: Dec 11, 2023, 08:20 PM
Fundamental Rating

1

Taking everything into account, UPH scores 1 out of 10 in our fundamental rating. UPH was compared to 35 industry peers in the Health Care Technology industry. Both the profitability and financial health of UPH have multiple concerns. UPH has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year UPH has reported negative net income.
  • UPH had a negative operating cash flow in the past year.
UPH Yearly Net Income VS EBIT VS OCF VS FCFUPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 -100M -200M -300M

1.2 Ratios

  • Looking at the Return On Assets, with a value of -31.98%, UPH is in line with its industry, outperforming 48.84% of the companies in the same industry.
  • Looking at the Return On Equity, with a value of -117.29%, UPH is doing worse than 62.79% of the companies in the same industry.
  • UPH's Return On Invested Capital of 1.59% is amongst the best of the industry. UPH outperforms 86.05% of its industry peers.
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROIC 1.59%
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
UPH Yearly ROA, ROE, ROICUPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 -50 -100 -150 -200

1.3 Margins

  • The Operating Margin of UPH (0.90%) is better than 81.40% of its industry peers.
  • UPH's Gross Margin of 45.52% is on the low side compared to the rest of the industry. UPH is outperformed by 60.47% of its industry peers.
Industry RankSector Rank
OM 0.9%
PM (TTM) N/A
GM 45.52%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
UPH Yearly Profit, Operating, Gross MarginsUPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 0 -100 -200

More info and screens

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), UPH is destroying value.
  • Compared to 1 year ago, UPH has more shares outstanding
  • Compared to 1 year ago, UPH has a worse debt to assets ratio.
UPH Yearly Shares OutstandingUPH Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 5M 10M 15M 20M
UPH Yearly Total Debt VS Total AssetsUPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 100M 200M 300M 400M 500M

2.2 Solvency

  • Based on the Altman-Z score of -3.70, we must say that UPH is in the distress zone and has some risk of bankruptcy.
  • The Altman-Z score of UPH (-3.70) is worse than 67.44% of its industry peers.
  • UPH has a Debt/Equity ratio of 0.03. This is a healthy value indicating a solid balance between debt and equity.
  • UPH has a Debt to Equity ratio of 0.03. This is in the better half of the industry: UPH outperforms 69.77% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z -3.7
ROIC/WACC0.24
WACC6.53%
UPH Yearly LT Debt VS Equity VS FCFUPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 0 100M 200M 300M

2.3 Liquidity

  • UPH has a Current Ratio of 0.13. This is a bad value and indicates that UPH is not financially healthy enough and could expect problems in meeting its short term obligations.
  • UPH's Current ratio of 0.13 is on the low side compared to the rest of the industry. UPH is outperformed by 97.67% of its industry peers.
  • A Quick Ratio of 0.13 indicates that UPH may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.13, UPH is doing worse than 97.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.13
Quick Ratio 0.13
UPH Yearly Current Assets VS Current LiabilitesUPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 20M 40M 60M 80M 100M

More info and screens

2

3. Growth

3.1 Past

  • UPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.97%, which is quite impressive.
  • UPH shows a small growth in Revenue. In the last year, the Revenue has grown by 3.24%.
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%

3.2 Future

  • Based on estimates for the next years, UPH will show a very strong growth in Earnings Per Share. The EPS will grow by 23.89% on average per year.
  • UPH is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.68% yearly.
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A

3.3 Evolution

UPH Yearly Revenue VS EstimatesUPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 50M 100M 150M
UPH Yearly EPS VS EstimatesUPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -5 -10

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for UPH. In the last year negative earnings were reported.
  • Also next year UPH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
UPH Price Earnings VS Forward Price EarningsUPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UPH is valued cheaply inside the industry as 90.70% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.37
UPH Per share dataUPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5

4.3 Compensation for Growth

  • UPH's earnings are expected to grow with 23.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y40.69%
EPS Next 3Y23.89%

More info and screens

0

5. Dividend

5.1 Amount

  • No dividends for UPH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

UPHEALTH INC

NYSE:UPH (12/11/2023, 8:20:46 PM)

0.3

+0.03 (+9.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)11-20
Earnings (Next)02-29
Inst Owners0.11%
Inst Owner Change0%
Ins Owners112.9%
Ins Owner Change0%
Market Cap5.33M
Revenue(TTM)153.15M
Net Income(TTM)-75.18M
Analysts82.5
Price Target5.24 (1646.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-362.92%
Min EPS beat(2)-624.95%
Max EPS beat(2)-100.89%
EPS beat(4)1
Avg EPS beat(4)-206.44%
Min EPS beat(4)-624.95%
Max EPS beat(4)19.85%
EPS beat(8)3
Avg EPS beat(8)-213.41%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)14.44%
Min Revenue beat(2)13.83%
Max Revenue beat(2)15.05%
Revenue beat(4)4
Avg Revenue beat(4)11.19%
Min Revenue beat(4)0.81%
Max Revenue beat(4)15.06%
Revenue beat(8)4
Avg Revenue beat(8)2%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-14.55%
PT rev (3m)-14.55%
EPS NQ rev (1m)43.5%
EPS NQ rev (3m)43.5%
EPS NY rev (1m)-11.26%
EPS NY rev (3m)-11.26%
Revenue NQ rev (1m)12.58%
Revenue NQ rev (3m)112482%
Revenue NY rev (1m)5.99%
Revenue NY rev (3m)5.99%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.08
P/tB N/A
EV/EBITDA 10.37
EPS(TTM)-7.7
EYN/A
EPS(NY)-0.22
Fwd EYN/A
FCF(TTM)-1.59
FCFYN/A
OCF(TTM)-1.31
OCFYN/A
SpS8.61
BVpS3.61
TBVpS-2.24
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -31.98%
ROE -117.29%
ROCE 2.01%
ROIC 1.59%
ROICexc 1.67%
ROICexgc N/A
OM 0.9%
PM (TTM) N/A
GM 45.52%
FCFM N/A
ROA(3y)-42.12%
ROA(5y)N/A
ROE(3y)-106.75%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.12
Cap/Depr 37.34%
Cap/Sales 3.21%
Interest Coverage 0.09
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.13
Quick Ratio 0.13
Altman-Z -3.7
F-Score5
WACC6.53%
ROIC/WACC0.24
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.97%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.46%
EPS Next Y72.87%
EPS Next 2Y40.69%
EPS Next 3Y23.89%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-15.49%
Revenue Next Year-7.87%
Revenue Next 2Y-37.26%
Revenue Next 3Y-0.68%
Revenue Next 5YN/A
EBIT growth 1Y102.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year214.28%
EBIT Next 3Y43.77%
EBIT Next 5YN/A
FCF growth 1Y45.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y52.9%
OCF growth 3YN/A
OCF growth 5YN/A

UPHEALTH INC / UPH FAQ

What is the ChartMill fundamental rating of UPHEALTH INC (UPH) stock?

ChartMill assigns a fundamental rating of 1 / 10 to UPH.


What is the valuation status of UPHEALTH INC (UPH) stock?

ChartMill assigns a valuation rating of 1 / 10 to UPHEALTH INC (UPH). This can be considered as Overvalued.


What is the profitability of UPH stock?

UPHEALTH INC (UPH) has a profitability rating of 2 / 10.


What is the financial health of UPHEALTH INC (UPH) stock?

The financial health rating of UPHEALTH INC (UPH) is 1 / 10.